Matches in SemOpenAlex for { <https://semopenalex.org/work/W1553243513> ?p ?o ?g. }
- W1553243513 endingPage "929" @default.
- W1553243513 startingPage "922" @default.
- W1553243513 abstract "Peroxisome-proliferator-activated receptor (PPAR) delta and adenosine monophosphate (AMP)-activated protein kinases (AMPKs) regulate the metabolic and contractile characteristics of myofibres. PPAR proteins are nuclear receptors that function as transcription factors and regulate the expression of multiple genes. AMPK has been described as a master metabolic regulator which also controls gene expression through the direct phosphorylation of some nuclear proteins. Since it was discovered that both PPARdelta agonists (GW1516) and AMPK activators (5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, known as AICAR) are very effective performance-enhancing substances in sedentary mice, the World Anti-doping Agency (WADA) included AICAR and GW1516 in the prohibited list of substances as metabolic modulators in the class ‘Hormone and metabolic modulators’. Thiazolidinediones are PPARgamma agonists that can induce similar biological effects to those of PPARdelta and PPARdelta-AMPK agonists. Thus in this study, the effects of pioglitazone on mitochondrial biogenesis and performance were evaluated. Blood glucose levels and the protein expression of the intermediates involved in the mitochondrial biogenesis pathway and the citrate synthase activity were determined in both gastrocnemius and soleus muscles. Maximal aerobic velocity (MAV), endurance capacity, and grip strength before and after the training period were also determined. The MAV endurance capacity and grip strength of trained animals significantly increased. We found that the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) and the nuclear respiratory factor-1 (NRF-1) protein content and citrate synthase activity significantly increased in the soleus muscle of trained animals. No effect of treatment was found. Therefore in our study, pioglitazone administration did not affect mitochondrial biogenesis signaling pathway. Copyright © 2013 John Wiley & Sons, Ltd." @default.
- W1553243513 created "2016-06-24" @default.
- W1553243513 creator A5002966196 @default.
- W1553243513 creator A5024401901 @default.
- W1553243513 creator A5031111821 @default.
- W1553243513 date "2013-11-20" @default.
- W1553243513 modified "2023-10-18" @default.
- W1553243513 title "PPARgamma agonist pioglitazone does not enhance performance in mice" @default.
- W1553243513 cites W1775749144 @default.
- W1553243513 cites W1834586190 @default.
- W1553243513 cites W1964060221 @default.
- W1553243513 cites W1975718825 @default.
- W1553243513 cites W1982027543 @default.
- W1553243513 cites W1996337656 @default.
- W1553243513 cites W1996885736 @default.
- W1553243513 cites W2002415424 @default.
- W1553243513 cites W2007914493 @default.
- W1553243513 cites W2008632158 @default.
- W1553243513 cites W2011951281 @default.
- W1553243513 cites W2018427433 @default.
- W1553243513 cites W2020444654 @default.
- W1553243513 cites W2023984767 @default.
- W1553243513 cites W2027997839 @default.
- W1553243513 cites W2030608745 @default.
- W1553243513 cites W2031285535 @default.
- W1553243513 cites W2047857407 @default.
- W1553243513 cites W2051636465 @default.
- W1553243513 cites W2053269710 @default.
- W1553243513 cites W2061075485 @default.
- W1553243513 cites W2062748949 @default.
- W1553243513 cites W2068297991 @default.
- W1553243513 cites W2075909244 @default.
- W1553243513 cites W2077645437 @default.
- W1553243513 cites W2079833285 @default.
- W1553243513 cites W2084362716 @default.
- W1553243513 cites W2085410812 @default.
- W1553243513 cites W2087692517 @default.
- W1553243513 cites W2092867279 @default.
- W1553243513 cites W2102379590 @default.
- W1553243513 cites W2121836743 @default.
- W1553243513 cites W2138786739 @default.
- W1553243513 cites W2149965016 @default.
- W1553243513 cites W2157199218 @default.
- W1553243513 cites W2162178319 @default.
- W1553243513 cites W2176414067 @default.
- W1553243513 doi "https://doi.org/10.1002/dta.1587" @default.
- W1553243513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24259440" @default.
- W1553243513 hasPublicationYear "2013" @default.
- W1553243513 type Work @default.
- W1553243513 sameAs 1553243513 @default.
- W1553243513 citedByCount "8" @default.
- W1553243513 countsByYear W15532435132014 @default.
- W1553243513 countsByYear W15532435132015 @default.
- W1553243513 countsByYear W15532435132016 @default.
- W1553243513 countsByYear W15532435132021 @default.
- W1553243513 countsByYear W15532435132022 @default.
- W1553243513 countsByYear W15532435132023 @default.
- W1553243513 crossrefType "journal-article" @default.
- W1553243513 hasAuthorship W1553243513A5002966196 @default.
- W1553243513 hasAuthorship W1553243513A5024401901 @default.
- W1553243513 hasAuthorship W1553243513A5031111821 @default.
- W1553243513 hasConcept C104317684 @default.
- W1553243513 hasConcept C111133373 @default.
- W1553243513 hasConcept C11960822 @default.
- W1553243513 hasConcept C126322002 @default.
- W1553243513 hasConcept C127078168 @default.
- W1553243513 hasConcept C134018914 @default.
- W1553243513 hasConcept C169415338 @default.
- W1553243513 hasConcept C170493617 @default.
- W1553243513 hasConcept C181199279 @default.
- W1553243513 hasConcept C185592680 @default.
- W1553243513 hasConcept C187345961 @default.
- W1553243513 hasConcept C20251656 @default.
- W1553243513 hasConcept C2776780712 @default.
- W1553243513 hasConcept C2777180221 @default.
- W1553243513 hasConcept C2777229759 @default.
- W1553243513 hasConcept C2778384471 @default.
- W1553243513 hasConcept C2780124434 @default.
- W1553243513 hasConcept C28859421 @default.
- W1553243513 hasConcept C55493867 @default.
- W1553243513 hasConcept C555293320 @default.
- W1553243513 hasConcept C62231903 @default.
- W1553243513 hasConcept C63932345 @default.
- W1553243513 hasConcept C71924100 @default.
- W1553243513 hasConcept C7341990 @default.
- W1553243513 hasConcept C74438686 @default.
- W1553243513 hasConcept C77445288 @default.
- W1553243513 hasConcept C86339819 @default.
- W1553243513 hasConcept C86803240 @default.
- W1553243513 hasConcept C97029542 @default.
- W1553243513 hasConceptScore W1553243513C104317684 @default.
- W1553243513 hasConceptScore W1553243513C111133373 @default.
- W1553243513 hasConceptScore W1553243513C11960822 @default.
- W1553243513 hasConceptScore W1553243513C126322002 @default.
- W1553243513 hasConceptScore W1553243513C127078168 @default.
- W1553243513 hasConceptScore W1553243513C134018914 @default.
- W1553243513 hasConceptScore W1553243513C169415338 @default.
- W1553243513 hasConceptScore W1553243513C170493617 @default.